Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Rawan M, Alnazer"'
Publikováno v:
The Journal of Clinical Hypertension, Vol 23, Iss 2, Pp 201-207 (2021)
Abstract The aldosterone‐to‐renin ratio (ARR) is a common screening test for primary aldosteronism in hypertensives. However, there are many factors which could confound the ARR test result and reduce the accuracy of this test. The present review
Externí odkaz:
https://doaj.org/article/1eaee202b3b54df6b2870093551adc3c
Publikováno v:
The Journal of Clinical Hypertension, Vol 23, Iss 2, Pp 208-214 (2021)
Abstract The aldosterone‐to‐renin ratio (ARR) is a common screening test for primary aldosteronism in hypertensives. However, patients often use medications that could confound the ARR and, thereby, reduce the interpretability of the test. Since
Externí odkaz:
https://doaj.org/article/c95cb66f8a0343629179246fb6b78b9a
Publikováno v:
Cardiovascular Drugs and Therapy, 37(2), 283-289. Kluwer Academic Publishers
Purpose Hydralazine, doxazosin, and verapamil are currently recommended by the Endocrine Society as acceptable bridging treatment in those in whom full cessation of antihypertensive medication is infeasible during screening for primary aldosteronism
Publikováno v:
Journal of Hypertension, 41(4), 618-623. LIPPINCOTT WILLIAMS & WILKINS
Objective:The aldosterone-to-renin ratio (ARR) is widely used as a screening test for primary aldosteronism, but its determinants in patients with essential hypertension are not fully known. The purpose of the present investigation is to identify the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7591706414a4497d7d2a849092344c8a
https://cris.maastrichtuniversity.nl/en/publications/b4006fc2-5070-4995-81c8-0ff4e1717719
https://cris.maastrichtuniversity.nl/en/publications/b4006fc2-5070-4995-81c8-0ff4e1717719
Publikováno v:
The Journal of Clinical Hypertension
The aldosterone‐to‐renin ratio (ARR) is a common screening test for primary aldosteronism in hypertensives. However, patients often use medications that could confound the ARR and, thereby, reduce the interpretability of the test. Since it is not
Publikováno v:
Cardiovascular drugs and therapy.
Hydralazine, doxazosin, and verapamil are currently recommended by the Endocrine Society as acceptable bridging treatment in those in whom full cessation of antihypertensive medication is infeasible during screening for primary aldosteronism (PA). Th
Publikováno v:
Journal of Clinical Hypertension, 23(2), 201-207. Wiley
The Journal of Clinical Hypertension
The Journal of Clinical Hypertension
The aldosterone‐to‐renin ratio (ARR) is a common screening test for primary aldosteronism in hypertensives. However, there are many factors which could confound the ARR test result and reduce the accuracy of this test. The present review's object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774cf211f46c4f01309c93da54e6fa33
https://cris.maastrichtuniversity.nl/en/publications/4817afda-e1dd-41e2-a986-60ca61715e10
https://cris.maastrichtuniversity.nl/en/publications/4817afda-e1dd-41e2-a986-60ca61715e10
Publikováno v:
Journal of Hypertension. 39:e224
Publikováno v:
Journal of Hypertension. 39:e223
Publikováno v:
Journal of Hypertension. 39:e352